A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

Autor: Santoro, Armando, Assenat, Eric, Yau, Thomas, Delord, Jean-Pierre, Maur, Michela, Knox, Jennifer, Cattan, Stephane, Lee, Kyung-Hun, Del Conte, Gianluca, Springfeld, Christoph, Leo, Elisa, Xyrafas, Alexandros, Fairchild, Lauren, Mardjuadi, Feby, Chan, Stephen L.
Zdroj: In JHEP Reports April 2024 6(4)
Databáze: ScienceDirect